The impact of extended half‐life factor concentrates on prophylaxis for severe hemophilia in the United StatesLynn Malec, Margaret V. Ragni, Robert F. Sidonio et al.|American Journal of Hematology|2020Cited by 31
Fifth Åland Island conference on von Willebrand diseaseErik Berntorp, Jerzy Windyga, Tímea Szántó et al.|Haemophilia|2018Cited by 12
Adoption of Prophylaxis in the United States in the Era of Extended Half-Life Factor ConcentratesLynn Malec, Margaret V. Ragni, Gilbert White et al.|Blood|2018Cited by 2